Dow Down 0.92% Nasdaq Down 0.83%

Momenta Pharmaceuticals Inc. (MNTA)

-NasdaqGS
10.66 Down 0.47(4.22%) 4:00PM EDT
Prev Close:11.13
Open:11.15
Bid:10.55 x 100
Ask:N/A
1y Target Est:15.38
Beta:1.78
Earnings Date:Nov 3 - Nov 7 (Est.)
Day's Range:10.52 - 11.20
52wk Range:9.38 - 19.90
Volume:768,515
Avg Vol (3m):459,248
Market Cap:548.82M
P/E (ttm):N/A
EPS (ttm):-2.13
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for MNTA

Comparison

Symbol% ChgMkt Cap
MNTADown 4.22%548.82M
GSKUp 1.79%106.67B
SNYUp 0.92%138.11B
TEVADown 0.09%45.43B

Key Statistics

Forward P/E (1 yr):9.52
P/S (ttm):12.67
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.60
Quarterly EPS Est (Sep-14) :-0.43
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Momenta Pharmaceuticals, Inc., a biotechnology company, is engaged in the structural characterization, process engineering, and biologic systems analysis of complex molecules in the areas of complex generics, biosimilars, and novel drugs. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback